1. Home
  2. NTST vs NVCR Comparison

NTST vs NVCR Comparison

Compare NTST & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

N/A

Current Price

$20.76

Market Cap

1.5B

Sector

Real Estate

ML Signal

N/A

Logo NovoCure Limited

NVCR

NovoCure Limited

N/A

Current Price

$12.78

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NTST
NVCR
Founded
2019
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
NTST
NVCR
Price
$20.76
$12.78
Analyst Decision
Strong Buy
Buy
Analyst Count
13
6
Target Price
$20.62
$28.08
AVG Volume (30 Days)
1.7M
2.7M
Earning Date
05-07-2026
05-20-2026
Dividend Yield
4.21%
N/A
EPS Growth
150.00
21.79
EPS
0.08
N/A
Revenue
$195,006,000.00
$655,353,000.00
Revenue This Year
$15.47
$7.72
Revenue Next Year
$14.57
$6.74
P/E Ratio
$260.50
N/A
Revenue Growth
19.79
8.28
52 Week Low
$14.00
$9.82
52 Week High
$21.30
$21.55

Technical Indicators

Market Signals
Indicator
NTST
NVCR
Relative Strength Index (RSI) 63.81 50.83
Support Level $17.67 $12.66
Resistance Level N/A $14.13
Average True Range (ATR) 0.43 0.97
MACD -0.03 0.14
Stochastic Oscillator 64.05 42.70

Price Performance

Historical Comparison
NTST
NVCR

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: